OraSure Technologies (OSUR) said late Thursday it acquired diagnostic health company Sherlock Biosciences.
Financial details weren't disclosed.
This acquisition enhances OraSure's innovation pipeline by adding Sherlock's molecular diagnostics platform, which delivers results with sensitivity and specificity in a disposable format ideal for over-the-counter use, the company said.
Shares of OraSure were up 4% in after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.